Leadership Transition at Dollar Tree as CFO Prepares to Step Down Overview Dollar Tree has revealed that its Chief Financial Officer, Jeff Davis, who has been with the company since October 2022, plans to step down after the company’s fiscal […]
Dollar Tree Announces CFO Jeff Davis’ Resignation Read More »
The Face Shop, a notable skincare brand from Korea, has inaugurated its debut independent store in India, located at Manohar International Airport in Goa. This newly opened store will showcase an extensive range of offerings tailored to address diverse skincare
Introduction Nivea Polska, the Polish division of the renowned German skincare company Beiersdorf AG, is excited to reveal that it will set up an office in Warsaw for the first time. Details For this exciting venture, the company has signed
Nivea Polska/Beiersdorf Announces First Office in Warsaw Read More »
Warpaint London, known for its W7 and Technic makeup lines, has struck a deal to acquire Brand Architekts, another beauty industry player. Brand Architekts’ shareholders are set to receive a cash offer valued at 48p per share, which places the
Warpaint London Purchases Brand Architekts in £13.9m Agreement Read More »
Merck, recognized as MSD outside the US and Canada, has unveiled significant progress with its phase 3 KEYLYNK-001 clinical trial. This study examined the efficacy of Keytruda (pembrolizumab) combined with chemotherapy, succeeded by maintenance therapy with Lynparza (olaparib), with or
Medigene AG, a company specializing in oncology platforms aimed at the exploration and advancement of T cell receptor-directed therapies for cancer treatment, has unveiled its choice of Kirsten rat sarcoma viral oncogene homologue (KRAS) G12V, under the context of HLA
Medigene Identifies KRAS G12V as the Inaugural Target for TCR-Directed T Cell Engagers Read More »
IDEAYA Biosciences, Inc., a leader in precision oncology, has unveiled the nomination of its development candidate, IDE892, a prospective leading MTA-cooperative PRMT5 inhibitor. “We are thrilled to broaden our precision oncology portfolio with the nomination of our 7th development candidate,
Roche has shared results from a pivotal five-year follow-up study on the phase III POLARIX trial, which assesses the efficacy of Polivy (polatuzumab vedotin) alongside MabThera/Rituxan (rituximab), cyclophosphamide, doxorubicin, and prednisone (R-CHP), for treating newly diagnosed diffuse large B-cell lymphoma
Endo, Inc., a leading specialty pharmaceutical enterprise, has secured approval from the US Food and Drug Administration (FDA) to commence the commercial production of Vasostrict (vasopressin injection, USP) at their latest state-of-the-art aseptic manufacturing plant in Indore, India. Spanning over
Endo Gains FDA Green Light for Vasostrict Production at New Indore Facility Read More »
The Performance Evaluation Report outlines the methodologies and outcomes concerning the scientific validity, analytical performance, and clinical performance. A dedicated standard for this is EN 13612:2002, which is concise and does not contain extensive details. Additionally, there are three IMDRF
Template: Performance Evaluation Report (IVDD) Read More »